CNSX:CME

CME Group (CME) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
CME stock logo

About CME Group Stock (CNSX:CME)

Canadian Metals Inc. engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada. It explores for silica, zinc, polymetallic, gold, and silver ores. Canadian Metals Inc. was incorporated in 2012 and is headquartered in Montreal, Canada.

CME Stock News Headlines

Cantor's Lutnick Is Ready to Take on the CME
World’s biggest multibillionaire investor is buying THIS by the ton [picture]
Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.
CME Group: A Sleep Well At Night Company To Own
World’s biggest multibillionaire investor is buying THIS by the ton [picture]
Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.
CME Mar 2024 215.000 put
CME Apr 2024 250.000 call
CME Apr 2024 200.000 put
20 Countries with the Highest Cryptocurrency Adoption
See More Headlines
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Other Industrial Metals & Mining
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,370
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Beat Frei
    VP of Development & Project Finance , Interim President and CEO
  • Mr. Arnab Kumar De A.C.M.A.
    C.M.A., C.P.A., CGMA, M.B.A., Chief Financial Officer

CME Stock Analysis - Frequently Asked Questions

Should I buy or sell CME Group stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CME shares.
View CME analyst ratings
or view top-rated stocks.

What is CME Group's stock price target for 2024?

1 brokerages have issued 1 year target prices for CME Group's stock. Their CME share price targets range from $4.00 to $4.00. On average, they anticipate the company's stock price to reach $4.00 in the next twelve months.
View analysts price targets for CME
or view top-rated stocks among Wall Street analysts.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include Blueberries Medical (BBM), BioMarin Pharmaceutical (BMRN), nLIGHT (LASR), McDermott International (MDR), Avon Products (AVP), Aurinia Pharmaceuticals (AUPH), Astronics (ATRO), Archrock (AROC), Apollo Global Management (APO) and

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:CME) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners